Regen Biopharma increases authorized Series A Preferred shares to 739M

Regen BioPharma Inc

Series A Preferred Stock authorized shares increased to 739,000,000 via amendment to Certificate of Designation.
Amendment to Section 1 of the Certificate of Designation effective November 3, 2022.
Company presented at Emerging Growth Conference on November 9, 2022; video available via YouTube link.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.